Hey Teddy, yes, how management increases or not the price will be interesting, its possible that this recent holt to sales in EU maybe a 'reset' and they will just bump it up (no idea by how much) and see how it goes.
I guess if all goes well in the US and they start 'a new marketing' campaign in the EU, it sure will be interesting to see how it plays out. IMHO,this management looks to be real.
Regarding the reason for previous lack of up take, the proffesional jealuosy against Fiona Wood, maybe, but as the DrKelly mentions many times in that thread, its the lack of 'data'. I can pull up a small Australia trial report from 2009 that basically suggest that there is not enough data to confirm ReCells effiicencies and this probably the reason why the east coast surgeons have not use it. But who knows.
Why AVH's sale in US is better than Europe and Asia, page-12
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.93 |
Change
-0.040(1.01%) |
Mkt cap ! $219.7M | |||
| Open | High | Low | Value | Volume |
| $3.96 | $3.96 | $3.87 | $433.9K | 111.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 514 | $3.87 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.93 | 11205 | 2 |
View Market Depth
| Last trade - 16.10pm 22/11/2024 (20 minute delay) ? |
| AVH (ASX) Chart |
